The Company's Trilogy THV System is a TAVR system designed to treat patients with symptomatic, severe AR, and symptomatic, severe aortic stenosis who are at high surgical risk. The Trilogy THV System ...
In a trial that many are calling landmark, transcatheter aortic valve replacement had better outcomes than surveillance for ...
The RHEIA trial studied women with severe aortic stenosis and found that participants preferred transcatheter aortic valve replacement over surgical valve replacement.
The NOTION-3 study investigated if routine revascularization with PCI and transcatheter aortic valve replacement improves ...
A GENOME-wide association study (GWAS) has identified 17 genetic loci linked to the risk of developing aortic stenosis (AS), ...